<VariationArchive VariationID="1363110" VariationName="NM_024301.5(FKRP):c.1335_1336del (p.Leu446fs)" VariationType="Deletion" Accession="VCV001363110" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1396430" VariationID="1363110">
      <GeneList>
        <Gene Symbol="FKRP" FullName="fukutin related protein" GeneID="79147" HGNC_ID="HGNC:17997" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46744760" stop="46758575" display_start="46744760" display_stop="46758575" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47249302" stop="47261831" display_start="47249302" display_stop="47261831" Strand="+" />
          </Location>
          <OMIM>606596</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024301.5(FKRP):c.1335_1336del (p.Leu446fs)</Name>
      <CanonicalSPDI>NC_000019.10:46756784:CC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46756785" stop="46756786" display_start="46756785" display_stop="46756786" variantLength="2" positionVCF="46756784" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47260042" stop="47260043" display_start="47260042" display_stop="47260043" variantLength="2" positionVCF="47260041" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L446fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.46756785_46756786del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.46756785_46756786del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.47260042_47260043del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.47260042_47260043del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008898.2" sequenceAccession="NG_008898" sequenceVersion="2" change="g.15740_15741del">
            <Expression>NG_008898.2:g.15740_15741del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001039885.3" sequenceAccession="NM_001039885" sequenceVersion="3" change="c.1335_1336del">
            <Expression>NM_001039885.3:c.1335_1336del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001034974.1" sequenceAccession="NP_001034974" sequenceVersion="1" change="p.Leu446fs">
            <Expression>NP_001034974.1:p.Leu446fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024301.5" sequenceAccession="NM_024301" sequenceVersion="5" change="c.1335_1336del" MANESelect="true">
            <Expression>NM_024301.5:c.1335_1336del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077277.1" sequenceAccession="NP_077277" sequenceVersion="1" change="p.Leu446fs">
            <Expression>NP_077277.1:p.Leu446fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_761" sequenceAccession="LRG_761">
            <Expression>LRG_761:g.15740_15741del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_761t1" sequenceAccession="LRG_761t1">
            <Expression>LRG_761t1:c.1335_1336del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_761p1" sequenceAccession="LRG_761p1" change="p.Leu446fs">
            <Expression>LRG_761p1:p.Leu446fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1384878260" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024301.5(FKRP):c.1335_1336del (p.Leu446fs) AND Walker-Warburg congenital muscular dystrophy" Accession="RCV001902078" Version="5">
        <ClassifiedConditionList TraitSetID="31131">
          <ClassifiedCondition DB="MedGen" ID="C0265221">Walker-Warburg congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.1335_1336del (p.Leu446fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" Accession="RCV004571446" Version="1">
        <ClassifiedConditionList TraitSetID="1168">
          <ClassifiedCondition DB="MedGen" ID="C3150413">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16476814</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="31131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35635" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
                <XRef ID="Walker-Warburg+syndrome/7436" DB="Genetic Alliance" />
                <XRef ID="111504002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy, type A</ElementValue>
                <XRef ID="MONDO:0000171" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg syndrome</ElementValue>
                <XRef ID="899" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2599" />
                <XRef ID="2599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0265221" DB="MedGen" />
              <XRef ID="MONDO:0000171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10061" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0017" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+%28with+brain+and+eye+anomalies%29+type+A5/8068" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ElementValue>
                <XRef ID="MONDO:0013157" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A), which includes both the more severe Walker-Warburg syndrome (WWS) and the slightly less severe muscle-eye-brain disease (MEB), is an autosomal recessive disorder with characteristic brain and eye malformations, profound mental retardation, congenital muscular dystrophy, and death usually in the first years of life. It represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of DAG1 (128239), collectively known as 'dystroglycanopathies' (Beltran-Valero de Bernabe et al., 2004).
For a general phenotypic description and a discussion of genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see MDDGA1 (236670).</Attribute>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15625" />
                <XRef ID="15625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150413" DB="MedGen" />
              <XRef ID="MONDO:0013157" DB="MONDO" />
              <XRef Type="MIM" ID="613153" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4152810" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="641462|MedGen:C0265221" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002129630" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16476814</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the FKRP protein. Other variant(s) that disrupt this region (p.Gln460*) have been determined to be pathogenic (PMID: 16476814, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with FKRP-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu446Alafs*17) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 50 amino acid(s) of the FKRP protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.47260042_47260043del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265221" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9818717" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_024301.5:c.1335_1336del|OMIM:613153" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005057797" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024301.5:c.1335_1336del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613153" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9818717" TraitType="Disease" MappingType="XRef" MappingValue="613153" MappingRef="OMIM">
        <MedGen CUI="C3150413" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4152810" TraitType="Disease" MappingType="XRef" MappingValue="C0265221" MappingRef="MedGen">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

